|
1
|
Min J, Choi B, Han TS, Lee HJ, Kong SH,
Suh YS, Kim TH, Choe HN, Kim WH, Hur K and Yang HK: Methylation
levels of LINE-1 as a useful marker for venous invasion in both
FFPE and frozen tumor tissues of gastric cancer. Mol Cells.
40:346–354. 2017.PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lichthardt S, Kerscher A, Dietz UA,
Jurowich C, Kunzmann V, von Rahden BH, Germer CT and Wiegering A:
Original article: Role of adjuvant chemotherapy in a perioperative
chemotherapy regimen for gastric cancer. BMC Cancer. 16:6502016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Caruso S, Patriti A, Roviello F, De Franco
L, Franceschini F, Coratti A and Ceccarelli G: Laparoscopic and
robot-assisted gastrectomy for gastric cancer: Current
considerations. World J Gastroenterol. 22:5694–5717. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shi J, Gao P, Song Y, Chen X, Li Y, Zhang
C, Wang H and Wang Z: Efficacy and safety of taxane-based systemic
chemotherapy of advanced gastric cancer: A systematic review and
meta-analysis. Sci Rep. 7:53192017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chan WL, Yuen KK, Siu SW, Lam KO and Kwong
DL: Third-line systemic treatment versus best supportive care for
advanced/metastatic gastric cancer: A systematic review and
meta-analysis. Crit Rev Oncol Hematol. 116:68–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de
Leon GP, Chen Y, Finkle D, Venook R, Wu X, Ridgway J, et al:
Therapeutic antibody targeting of individual Notch receptors.
Nature. 464:1052–1057. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Zhou Y, Huang T, Cheng AS, Yu J,
Kang W and To KF: The interplay of LncRNA-H19 and its binding
partners in physiological process and gastric carcinogenesis. Int J
Mol Sci. 18:E4502017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sas-Chen A, Srivastava S and Yarden Y: The
short and the long: Non-coding RNAs and growth factors in cancer
progression. Biochem Soc Trans. 45:51–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang M and Du X: Noncoding RNAs in
gastric cancer: Research progress and prospects. World J
Gastroenterol. 22:6610–6618. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang J, Sun J, Wang J, Song Y, Gao P, Shi
J, Chen P and Wang Z: Long noncoding RNAs in gastric cancer:
functions and clinical applications. Onco Targets Ther. 9:681–697.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo X, Yang Z, Zhi Q, Wang D, Guo L, Li G,
Miao R, Shi Y and Kuang Y: Long noncoding RNA OR3A4 promotes
metastasis and tumorigenicity in gastric cancer. Oncotarget.
7:30276–30294. 2016.PubMed/NCBI
|
|
15
|
Qiu JJ, Lin YY, Ding JX, Feng WW, Jin HY
and Hua KQ: Long non-coding RNA ANRIL predicts poor prognosis and
promotes invasion/metastasis in serous ovarian cancer. Int J Oncol.
46:2497–2505. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou CC, Yang F, Yuan SX, Ma JZ, Liu F,
Yuan JH, Bi FR, Lin KY, Yin JH, Cao GW, et al: Systemic genome
screening identifies the outcome associated focal loss of long
noncoding RNA PRAL in hepatocellular carcinoma. Hepatology.
63:850–863. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nie W, Ge HJ, Yang XQ, Sun X, Huang H, Tao
X, Chen WS and Li B: LncRNA-UCA1 exerts oncogenic functions in
non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett.
371:99–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang JY, Weng MZ, Song FB, Xu YG, Liu Q,
Wu JY, Qin J, Jin T and Xu JM: Long noncoding RNA AFAP1-AS1
indicates a poor prognosis of hepatocellular carcinoma and promotes
cell proliferation and invasion via upregulation of the RhoA/Rac2
signaling. Int J Oncol. 48:1590–1598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun W, Yang Y, Xu C, Xie Y and Guo J:
Roles of long noncoding RNAs in gastric cancer and their clinical
applications. J Cancer Res Clin Oncol. 142:2231–2237. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, De W, Wang KM and Wang ZX: Lnc
RNA HOTAIR functions as a competing endogenous RNA to regulate HER2
expression by sponging miR-331-3p in gastric cancer. Mol Cancer.
13:922014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang J, Sun J, Wang J, Song Y, Gao P, Shi
J, Chen P and Wang Z: Long noncoding RNAs in gastric cancer:
Functions and clinical applications. Onco Targets Ther. 9:681–697.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lan WG, Xu DH, Xu C, Ding CL, Ning FL,
Zhou YL, Ma LB, Liu CM and Han X: Silencing of long non-coding RNA
ANRIL inhibits the development of multidrug resistance in gastric
cancer cells. Oncol Rep. 36:263–270. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He X, Tan X, Wang X, Jin H, Liu L, Ma L,
Yu H and Fan Z: C-Myc-activated long noncoding RNA CCAT1 promotes
colon cancer cell proliferation and invasion. Tumour Biol.
35:12181–12188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu TP, Huang MD, Xia R, Liu XX, Sun M, Yin
L, Chen WM, Han L, Zhang EB, Kong R, et al: Decreased expression of
the long non-coding RNA FENDRR is associated with poor prognosis in
gastric cancer and FENDRR regulates gastric cancer cell metastasis
by affecting fibronectin1 expression. J Hematol Oncol. 7:632014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma HW, Xie M, Sun M, Chen TY, Jin RR, Ma
TS, Chen QN, Zhang EB, He XZ, De W and Zhang ZH: The pseudogene
derived long noncoding RNA DUXAP8 promotes gastric cancer cell
proliferation and migration via epigenetically silencing PLEKHO1
expression. Oncotarget. 8:52211–52224. 2016.PubMed/NCBI
|
|
28
|
Deng QJ, Xie LQ and Li H: Overexpressed
MALAT1 promotes invasion and metastasis of gastric cancer cells via
increasing EGFL7 expression. Life Sci. 157:38–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ye H, Liu K and Qian K: Overexpression of
long noncoding RNA HOTTIP promotes tumor invasion and predicts poor
prognosis in gastric cancer. Onco Targets Ther. 9:2081–2088.
2016.PubMed/NCBI
|
|
30
|
Bo H, Gong Z, Zhang W, Li X, Zeng Y, Liao
Q, Chen P, Shi L, Lian Y, Jing Y, et al: Upregulated long
non-coding RNA AFAP1-AS1 expression is associated with progression
and poor prognosis of nasopharyngeal carcinoma. Oncotarget.
6:20404–20418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang F, Ni H, Sun F, Li M and Chen L:
Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis
and promotes tumorigenesis in colorectal cancer. Biomed
Pharmacother. 81:152–159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang F, Lyu S, Dong S, Liu Y, Zhang X and
Wang O: Expression profile analysis of long noncoding RNA in
HER-2-enriched subtype breast cancer by next-generation sequencing
and bioinformatics. Onco Targets Ther. 9:761–772. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou XL, Wang WW, Zhu WG, Yu CH, Tao GZ,
Wu QQ, Song YQ, Pan P and Tong YS: High expression of long
non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor
prognosis in patients with esophageal squamous cell carcinoma
treated with definitive chemoradiotherapy. Mol Carcinog.
55:2095–2105. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Deng J, Liang Y, Liu C, He S and Wang S:
The up-regulation of long non-coding RNA AFAP1-AS1 is associated
with the poor prognosis of NSCLC patients. Biomed Pharmacother.
75:8–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
